Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2005 Apr;60(4):282–287. doi: 10.1136/thx.2004.033688

Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma

J Tomlinson 1, A McMahon 1, R Chaudhuri 1, J Thompson 1, S Wood 1, N Thomson 1
PMCID: PMC1747368  PMID: 15790982

Abstract

Background: Cigarette smokers with asthma are insensitive to short term inhaled corticosteroid therapy, but efficacy when given for a longer duration at different doses is unknown.

Methods: Ninety five individuals with mild asthma were recruited to a multicentre, randomised, double blind, parallel group study comparing inhaled beclomethasone in doses of 400 µg or 2000 µg daily for 12 weeks in smokers and non-smokers. The primary end point was the change in morning peak expiratory flow (PEF). Secondary end points included evening PEF, use of reliever inhaler, number of asthma exacerbations, spirometric parameters, and asthma control score.

Results: After 12 weeks of inhaled beclomethasone there was a considerable difference between the morning PEF measurements of smokers and non-smokers with asthma (–18 (95% CI –35 to –1), adjusted p = 0.035). Among those receiving 400 µg daily there was a difference between the mean (95% CI) morning PEF (l/min) in smokers and non-smokers (–25 (95% CI –45 to –4), adjusted p = 0.019) and in the number of asthma exacerbations (6 v 1 in smokers and non-smokers, respectively, p = 0.007). These differences were reduced between smokers and non-smokers receiving 2000 µg inhaled beclomethasone daily.

Conclusions: Compared with non-smokers, smokers with mild persistent asthma are insensitive to the therapeutic effect of low dose inhaled corticosteroid treatment administered for a 12 week period. The disparity of the response between smokers and non-smokers appears to be reduced with high dose inhaled corticosteroid. These findings have important implications for the management of individuals with mild asthma who smoke.

Full Text

The Full Text of this article is available as a PDF (113.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Althuis M. D., Sexton M., Prybylski D. Cigarette smoking and asthma symptom severity among adult asthmatics. J Asthma. 1999 May;36(3):257–264. doi: 10.3109/02770909909075409. [DOI] [PubMed] [Google Scholar]
  2. Celli B. R., MacNee W., ATS/ERS Task Force Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004 Jun;23(6):932–946. doi: 10.1183/09031936.04.00014304. [DOI] [PubMed] [Google Scholar]
  3. Chalmers G. W., Macleod K. J., Little S. A., Thomson L. J., McSharry C. P., Thomson N. C. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax. 2002 Mar;57(3):226–230. doi: 10.1136/thorax.57.3.226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chaudhuri Rekha, Livingston Eric, McMahon Alex D., Thomson Lorna, Borland William, Thomson Neil C. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med. 2003 Jul 31;168(11):1308–1311. doi: 10.1164/rccm.200304-503OC. [DOI] [PubMed] [Google Scholar]
  5. Johansson S. G., Hourihane J. O., Bousquet J., Bruijnzeel-Koomen C., Dreborg S., Haahtela T., Kowalski M. L., Mygind N., Ring J., van Cauwenberge P. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 2001 Sep;56(9):813–824. doi: 10.1034/j.1398-9995.2001.t01-1-00001.x. [DOI] [PubMed] [Google Scholar]
  6. Jonsson Steinn, Thorsteinsdottir Unnur, Gudbjartsson Daniel F., Jonsson Hjortur H., Kristjansson Kristleifur, Arnason Sigurdur, Gudnason Vilmundur, Isaksson Helgi J., Hallgrimsson Jonas, Gulcher Jeffrey R. Familial risk of lung carcinoma in the Icelandic population. JAMA. 2004 Dec 22;292(24):2977–2983. doi: 10.1001/jama.292.24.2977. [DOI] [PubMed] [Google Scholar]
  7. Juniper E. F., O'Byrne P. M., Guyatt G. H., Ferrie P. J., King D. R. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999 Oct;14(4):902–907. doi: 10.1034/j.1399-3003.1999.14d29.x. [DOI] [PubMed] [Google Scholar]
  8. Juniper E. F., O'Byrne P. M., Roberts J. N. Measuring asthma control in group studies: do we need airway calibre and rescue beta2-agonist use? Respir Med. 2001 May;95(5):319–323. doi: 10.1053/rmed.2001.1034. [DOI] [PubMed] [Google Scholar]
  9. Lanes S. F., García Rodríguez L. A., Huerta C. Respiratory medications and risk of asthma death. Thorax. 2002 Aug;57(8):683–686. doi: 10.1136/thorax.57.8.683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lange P., Parner J., Vestbo J., Schnohr P., Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998 Oct 22;339(17):1194–1200. doi: 10.1056/NEJM199810223391703. [DOI] [PubMed] [Google Scholar]
  11. Lipworth B. J. Fortnightly review: modern drug treatment of chronic asthma. BMJ. 1999 Feb 6;318(7180):380–384. doi: 10.1136/bmj.318.7180.380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Marquette C. H., Saulnier F., Leroy O., Wallaert B., Chopin C., Demarcq J. M., Durocher A., Tonnel A. B. Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis. 1992 Jul;146(1):76–81. doi: 10.1164/ajrccm/146.1.76. [DOI] [PubMed] [Google Scholar]
  13. Pedersen B., Dahl R., Karlström R., Peterson C. G., Venge P. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking. Am J Respir Crit Care Med. 1996 May;153(5):1519–1529. doi: 10.1164/ajrccm.153.5.8630596. [DOI] [PubMed] [Google Scholar]
  14. Raherison C., Baldi I., Tunon-De-Lara J. M., Taytard A., Annesi-Maesano I. Asthma phenotypes according to the timing of smoking onset in young adults. Int J Tuberc Lung Dis. 2003 Jan;7(1):84–92. [PubMed] [Google Scholar]
  15. Reddel H. K., Salome C. M., Peat J. K., Woolcock A. J. Which index of peak expiratory flow is most useful in the management of stable asthma? Am J Respir Crit Care Med. 1995 May;151(5):1320–1325. doi: 10.1164/ajrccm.151.5.7735580. [DOI] [PubMed] [Google Scholar]
  16. Silverman Robert A., Boudreaux Edwin D., Woodruff Prescott G., Clark Sunday, Camargo Carlos A., Jr Cigarette smoking among asthmatic adults presenting to 64 emergency departments. Chest. 2003 May;123(5):1472–1479. doi: 10.1378/chest.123.5.1472. [DOI] [PubMed] [Google Scholar]
  17. Thomson N. C., Chaudhuri R., Livingston E. Asthma and cigarette smoking. Eur Respir J. 2004 Nov;24(5):822–833. doi: 10.1183/09031936.04.00039004. [DOI] [PubMed] [Google Scholar]
  18. Venables K. M., Burge P. S., Davison A. G., Newman Taylor A. J. Peak flow rate records in surveys: reproducibility of observers' reports. Thorax. 1984 Nov;39(11):828–832. doi: 10.1136/thx.39.11.828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Walsh L. J., Wong C. A., Cooper S., Guhan A. R., Pringle M., Tattersfield A. E. Morbidity from asthma in relation to regular treatment: a community based study. Thorax. 1999 Apr;54(4):296–300. doi: 10.1136/thx.54.4.296. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES